Market Exclusive

Analyst Downgrades – NASDAQ:PTI – Proteostasis Therapeutics (NASDAQ:PTI) Stock Gets Downgraded By Royal Bank of Canada from Outperform ➝ Sector Perform to

Analyst Ratings For NASDAQ:PTI – Proteostasis Therapeutics (NASDAQ:PTI)

Today, NASDAQ:PTI – Proteostasis Therapeutics (NASDAQ:PTI) stock was downgraded by Royal Bank of Canada from Outperform ➝ Sector Perform to with a price target of $11.00 ➝ $5.00.

Some recent analyst ratings include

Recent Insider Trading Activity For NASDAQ:PTI – Proteostasis Therapeutics (NASDAQ:PTI)
NASDAQ:PTI – Proteostasis Therapeutics (NASDAQ:PTI) has insider ownership of 19.80% and institutional ownership of 67.30%.

Recent Trading Activity for NASDAQ:PTI – Proteostasis Therapeutics (NASDAQ:PTI)
Shares of NASDAQ:PTI – Proteostasis Therapeutics closed the previous trading session at 3.22 down -1.69 34.39% with 1861224 shares trading hands.

Exit mobile version